Skip to content

Drug interactions

Elvitegravir / cobicistat / emtricitabine / tenofovir df + Losartan

Severity: Moderate

Elvitegravir / cobicistat / emtricitabine / tenofovir df and Losartan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cobicistat inhibits CYP3A4 and may modestly alter losartan metabolism, while elvitegravir may weakly induce CYP2C9, which forms losartan's active metabolite. Net effects on losartan exposure and effect are unpredictable and usually modest.

What this interaction means in plain words

Elvitegravir / cobicistat / emtricitabine / tenofovir df and Losartan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Cobicistat inhibits CYP3A4 and elvitegravir may induce CYP2C9, both involved in losartan biotransformation.

What to do

Monitor blood pressure and adjust the losartan dose to response. Watch for hypotension or reduced antihypertensive effect after starting or stopping the regimen.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elvitegravir / cobicistat / emtricitabine / tenofovir df and Losartan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Elvitegravir / cobicistat / emtricitabine / tenofovir df with Losartan?

MediHelp rates the interaction as moderate. Elvitegravir / cobicistat / emtricitabine / tenofovir df and Losartan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cobicistat inhibits CYP3A4 and may modestly alter losartan metabolism, while elvitegravir may weakly induce CYP2C9, which forms losartan's active metabolite. Net effects on losartan exposure and effect are unpredictable and usually modest.

How serious is the interaction between Elvitegravir / cobicistat / emtricitabine / tenofovir df and Losartan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood pressure and adjust the losartan dose to response. Watch for hypotension or reduced antihypertensive effect after starting or stopping the regimen.

What other medicines interact with Losartan?

MediHelp also lists interactions of Losartan with, for example, Aliskiren, Sparsentan, Amifostine. The full list is on the Losartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in